Innoviva (INVA) Dividends Paid - Common Growth (1y) (2015 - 2022)
Innoviva (INVA) Dividends Paid - Common Growth (1y) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.26% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Innoviva | 1.58 Bn | 979.49 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 50.59% |
| Jun 30, 2022 | -52.65% |
| Mar 31, 2022 | -69.43% |
| Jun 30, 2021 | 65.91% |
| Mar 31, 2021 | 34.63% |
| Dec 31, 2020 | 123.83% |
| Jun 30, 2020 | 110,372.73% |
| Dec 31, 2019 | -443.72% |
| Sep 30, 2019 | 430.02% |
| Jun 30, 2019 | -98.64% |
| Dec 31, 2018 | 2,171.85% |
| Sep 30, 2018 | 1,262.33% |
| Jun 30, 2018 | 1,307.46% |
| Mar 31, 2018 | 34.33% |
| Dec 31, 2017 | 107.69% |
| Sep 30, 2017 | 180.77% |
| Jun 30, 2017 | -154.03% |
| Mar 31, 2017 | -90.68% |
| Dec 31, 2016 | -65.24% |
| Sep 30, 2016 | -99.82% |